The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys.

The aging process is associated with a significant reduction in circulating GH and insulin-like growth factor I (IGF-I) levels. During this period, immune function also declines. Rodent data suggest that treatment with recombinant human GH (rhGH) or rhIGF-I enhances immune function in normal adult mice. To determine whether rhGH and/or rhIGF-I treatment could improve immune function in aged female rhesus monkeys, we administered rhIGF-I (120 micrograms/kg x day), rhGH (100 micrograms/kg x day), a combination of therapies, or excipient alone by sc infusion using Alzet pumps over a 7-week period. At 28 days, the pumps were replaced, and the animals were bled and immunized with tetanus toxoid. At the end of the 7-week period, the animals were killed. rhGH and rhIGF-I increased serum GH and IGF-I levels, respectively; rhGH and rhIGF-I in combination induced the highest serum IGF-I levels (906 +/- 261 ng/ml vs. control, 185 +/- 36 ng/ml at death). rhGH and rhIGF-I also increased IGFBP-3 levels. rhGH infusion resulted in the most marked changes in lymph node and splenic reactivity, as determined by histological assessment. Lymph nodes from the rhGH-treated animals showed changes from baseline indicating a stimulated reactive state. Both rhGH and rhIGF-I had effects on lymphocyte phenotype, but there were different responses in blood compared to spleen and lymph nodes. In the peripheral blood, the percent B cells and percent CD8 cell count rose after rhIGF-I therapy, with a fall in the CD4/CD8 ratio. In the spleen, on the other hand, the CD4/CD8 ratio nearly doubled (0.33 +/- 0.12 vs. 0.53 +/ 0.12) after rhIGF- I therapy. In the spleen, the combination of rhGH and rhIGF- I increased the percent T cells from 26.7 +/- 2.3 to 42.4 +/- 4.4 and the CD4/CD8 ration to 0.71 +/- 0.11. Both rhGH and rhIGF-I increased in vivo (antibody titer to tetanus toxoid) responses by lymphocytes, and rhGH increased Con-A- induced DNA synthesis in vitro. These results confirm the rodent data showing that rhGH and rhIGF-I cause beneficial changes in immune function and suggest that further investigation is warranted to assess their therapeutic potential.

[1]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[2]  C. Roberts,et al.  Role of GH and IGF-I in the regulation of IGF-I, IGF-I receptor and IGF binding protein gene expression in the rat spleen , 1994, Regulatory Peptides.

[3]  C. Roberts,et al.  Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-binding protein (IGFBP)-2 gene expression in spleens of juvenile rats. , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[4]  D. Taub,et al.  Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. , 1994, The Journal of clinical investigation.

[5]  R. Clark,et al.  In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. , 1994, Journal of immunology.

[6]  H. Kimata,et al.  Effect of growth hormone and insulin-like growth factor-I on immunoglobulin production by and growth of human B cells. , 1994, The Journal of clinical endocrinology and metabolism.

[7]  J. Strasser,et al.  Immunological effects of insulin‐like growth factor‐I–enhancement of immunoglobulin synthesis , 1994, Clinical and experimental immunology.

[8]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[9]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[10]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[11]  R. Baxter,et al.  Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. , 1993, The Journal of clinical investigation.

[12]  Yong Ming Li,et al.  Growth Hormone, Insulin-like Growth Factor I, and Immune Function , 1993 .

[13]  Yong Ming Li,et al.  Growth hormone, prolactin, and insulin-like growth factors: New jobs for old players , 1992, Brain, Behavior, and Immunity.

[14]  A. Globerson,et al.  Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow , 1992, Brain, Behavior, and Immunity.

[15]  A. Hoffman,et al.  Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. , 1992, The Journal of clinical endocrinology and metabolism.

[16]  H. Mikawa,et al.  Recombinant human growth hormone stimulates B cell immunoglobulin synthesis and proliferation in serum-free medium. , 1992, Acta endocrinologica.

[17]  K. Dorshkind,et al.  Insulin-like growth factor-I regulates pro-B cell differentiation. , 1992, Blood.

[18]  T. Quattrin,et al.  Diagnostic Significance of Urinary Growth Hormone Measurements in Children with Growth Failure: Correlation between Serum and Urine Growth Hormone , 1991, Pediatric Research.

[19]  K. Kelley.  The Role of Growth Hormone in Modulation of the Immune Response a , 1990, Annals of the New York Academy of Sciences.

[20]  R. Palmiter,et al.  Growth enhancement of transgenic mice expressing human insulin-like growth factor I. , 1988, Endocrinology.

[21]  W. Kiess,et al.  Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone. , 1988, Clinical immunology and immunopathology.

[22]  E. Froesch,et al.  Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Hammer,et al.  Growth allometry of the organs in giant transgenic mice. , 1987, Endocrinology.

[24]  R. Hammer,et al.  Role of growth hormone in regulating T‐Dependent immune events in aged, nude, and transgenic rodents , 1987, Journal of neuroscience research.

[25]  B. Nelson,et al.  Immunologic response in an elderly population with a mean age of 85. , 1986, The American journal of medicine.

[26]  J. Nagel,et al.  Human B cell function in responder and non-responder individuals. II. The role of T helper cells in promoting the PWM-induced B cell production of immunoprotein. , 1983, Clinical and experimental immunology.

[27]  D. Golde,et al.  Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. , 1981, Blood.

[28]  W. Adler,et al.  Effect of age upon primary alloantigen recognition by mouse spleen cells. , 1971, Journal of immunology.